Atria Investments Inc Buys 15,416 Shares of Sanofi $SNY

Atria Investments Inc increased its stake in Sanofi (NASDAQ:SNY) by 13.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 132,716 shares of the company’s stock after purchasing an additional 15,416 shares during the period. Atria Investments Inc’s holdings in Sanofi were worth $6,431,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of SNY. Flagship Harbor Advisors LLC bought a new position in Sanofi in the 4th quarter worth approximately $25,000. Measured Wealth Private Client Group LLC bought a new position in Sanofi in the 3rd quarter worth approximately $29,000. Palisade Asset Management LLC bought a new position in Sanofi in the 3rd quarter worth approximately $30,000. First Horizon Corp acquired a new stake in Sanofi during the 3rd quarter worth $33,000. Finally, Sittner & Nelson LLC acquired a new stake in Sanofi during the 3rd quarter worth $47,000. Institutional investors own 14.03% of the company’s stock.

Analyst Upgrades and Downgrades

SNY has been the subject of a number of analyst reports. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Sanofi in a report on Friday, January 16th. UBS Group reaffirmed a “neutral” rating on shares of Sanofi in a report on Friday, January 16th. Sanford C. Bernstein raised shares of Sanofi to a “strong-buy” rating in a report on Thursday, March 19th. Morgan Stanley set a $52.00 target price on shares of Sanofi in a report on Friday, May 1st. Finally, Weiss Ratings raised shares of Sanofi from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday. Two investment analysts have rated the stock with a Strong Buy rating, three have given a Buy rating and ten have issued a Hold rating to the stock. According to data from MarketBeat, Sanofi presently has an average rating of “Hold” and a consensus price target of $51.00.

Sanofi Price Performance

SNY opened at $42.69 on Friday. The company has a fifty day moving average price of $45.60 and a two-hundred day moving average price of $47.46. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.22 and a current ratio of 1.01. Sanofi has a 52 week low of $42.33 and a 52 week high of $53.36. The firm has a market capitalization of $104.12 billion, a PE ratio of 11.92, a P/E/G ratio of 1.06 and a beta of 0.35.

Sanofi Increases Dividend

The company also recently declared an annual dividend, which will be paid on Wednesday, June 3rd. Stockholders of record on Monday, May 4th will be issued a $2.4225 dividend. This is a positive change from Sanofi’s previous annual dividend of $2.04. The ex-dividend date of this dividend is Monday, May 4th. This represents a dividend yield of 559.0%. Sanofi’s dividend payout ratio (DPR) is presently 49.44%.

Sanofi Profile

Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company headquartered in France that researches, develops, manufactures and markets prescription medicines, vaccines and consumer healthcare products. The company operates across multiple therapeutic areas, including immunology, rare diseases, oncology, cardiovascular and metabolic diseases, and vaccines through its Sanofi Pasteur division. Sanofi sells products to hospitals, clinics, governments and retail pharmacies, with a broad global footprint and significant presence in Europe, North America and emerging markets.

Key commercial offerings include specialty biologics and established small-molecule medicines.